Tattoo-less radiation treatment is the future of cancer care
Opinion: The tiny tattoos of radiation therapy many cancer patients receive take an emotional toll — but they’re increasingly unnecessary.
Related Articles
The PACT Act—Expanding Coverage and Access for Veterans
This Viewpoint examines the implementation of the Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act, known as the PACT Act,…
North Devon hospital accommodation block plans revealed
Plans show a new four-storey block to replace two existing 50-year-old buildings.
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from its…
VMware Live Recovery Support For Google Cloud VMware Engine Recovery Environments Enables Increased Flexibility
Broadcom and Google Cloud’s continued commitment to solving our customer’s most pressing challenges stems from our joint goal to enable every organization’s ability to digitally…
Bandhavgarh: Alarm over death of 10 elephants in India national park
A toxicology report says that the elephants may have died from eating a millet crop infected with fungus.
Apple reportedly devising plans to enter smart glasses market
Apple is conducting an internal study, dubbed ‘Atlas’, to gather employee feedback on smart glasses currently available in the market.
‘MAHA’ is moving into Trump’s White House. Here’s who RFK Jr. could bring along for the ride
Here are 10 influencers, entrepreneurs and lawmakers who are amplifying Robert F. Kennedy Jr.’s “Make America Healthy Again” message.
Prudential pioneers use of Google’s generative AI for medical claims | Frontier Enterprise
Prudential is using MedLM, Google’s family of foundation models fine-tuned for healthcare industry use cases, to improve the accuracy and efficiency of medical insurance claim…
These 6 companies are using AI to streamline clinical trials for pharma
Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.
SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study
Objective To investigate the association between sodium-glucose cotransporter-2 (SGLT-2) inhibitor use and risk of all cause mortality among patients with heart failure with reduced ejection…
